Investor Summary

Patented, music-driven neurorehabilitation for Parkinson’s and TBI.
Purpose: Restoring hope and motor function to those with neurological challenges through the power of music.

Get the investor packet See the raise
CBMT-approved curriculum
Institutional pilots (Evergreen Commons)
Academic partners (Northwestern + Hope)
The Problem Solution & Moat Evidence & Traction Momentum Team The Raise

1) The Problem

Parkinson’s is growing fast, and many rehab options still struggle with adherence—people don’t keep doing them. The result is a gap between what patients need and what most programs deliver.

The crisis

Parkinson’s is the fastest-growing neurological condition globally, with 90,000 new U.S. diagnoses each year.

The clinical gap

Rehab often lacks high-adherence tools that stabilize movement while keeping people mentally engaged.

The market

A major unmet need in the $3.7B+ PD care market—now expanding into TBI.

2) The Solution & Moat

Theraplaying moves “rehab” closer to “art”—because people return to what gives them purpose. It’s built to work in real clinical settings and to track progress over time.

What it is

A certified 12-week program combining patented Strum Perfect hardware with proprietary accelerometer tracking.

Why it’s defensible

Patents submitted for the Theraplaying program, Strum Perfect hardware, and proprietary accelerometer technology.

Why clinicians can adopt it

CBMT-approved curriculum, with a specialized path built for PT/OT integration.

3) Evidence & Traction

This isn’t just a concept. Theraplaying is building a clear clinical foundation and showing up where the field pays attention.

  • Peer-reviewed: Research featured in the Journal of Music, Technology and Education and the Journal of Music and Medicine (Jan 2026).
  • Global stage: Accepted for the 2025 MDS Congress; invited to the 2026 World Parkinson’s Congress.
  • Research partners: Collaborations with Northwestern University and Hope College.
  • Institutional demand: Signed LOIs from caregiving institutions and active pilots at Evergreen Commons.

“I notice the Parkinson’s symptoms are lessened... it gives him a sense of purpose and hope.”

— Linda Zoerhof, caregiver for a Stage 5 PD patient

4) Business Momentum

Proof is showing up in awards, grants, and broad awareness.

Awards & grants

1st Place winner of Start Garden 100; awarded two Michigan BAF grants.

Media

Featured on NBC, WGN, and FOX, with a forthcoming ABC National story.

Why this matters

Awareness helps destigmatize Parkinson’s and builds demand while institutional rollout ramps.

5) Team & Collaborators

Mission-led and science-rooted—built alongside institutions that take evidence seriously.

Leadership

James Lenger: Inventor of Strum Perfect and Principal Investigator for Theraplaying. Former Team USA athlete.

Advisory strength

Deep ties to the Movement Disorder Society and academic research institutions.

Academic support

Researching alongside Northwestern University and Hope College to keep the work anchored in science.

6) The Raise

Ask: Raising $[Amount] (Pre-Seed) to move from pilot to institutional rollout and expand into TBI.

  • Scale operations: Fulfill institutional LOIs and reach patients in care facilities.
  • Scale manufacturing: Increase Strum Perfect hardware production to support rollout.
  • Finalize research: Complete TBI testing to serve a new patient population.
  • Outreach: Present at the World Parkinson’s Congress to help set a higher standard for music-based neuro-rehab.